Literature DB >> 26686788

A Vision "Bolt-On" Item Could Increase the Discriminatory Power of the EQ-5D Index Score.

Nan Luo1, Xingzhi Wang2, Marcus Ang3, Eric A Finkelstein4, Tin Aung5, Tien-Yin Wong5, Ecosse Lamoureux6.   

Abstract

BACKGROUND: Recently, a vision "bolt-on" EuroQol five-dimensional questionnaire (EQ-5D) was developed and tentative utility values (i.e., a "value set") for this new descriptive system were estimated.
OBJECTIVES: To compare the discriminatory power of this bolt-on and standard utility-based EQ-5D health indices.
METHODS: Cross-sectional data on the (3-level) vision bolt-on EQ-5D were collected through face-to-face interviews with 500 and 336 individuals with and without visual impairment, respectively. To assess the discriminatory power of the vision bolt-on index relative to the standard EQ-5D index developed in the vision bolt-on valuation study, 16 pairs of mutually exclusive subgroups of individuals defined by the individuals' visual acuity and responses to the 14-item visual function questionnaire were compared pairwise. The absolute mean difference in the two index scores and the corresponding F statistic derived from the comparisons were used as measures of discriminatory power.
RESULTS: The absolute mean difference in the bolt-on index score was larger than that in the standard EQ-5D index score in 14 of the 16 comparisons. The bolt-on index score exhibited a larger F-statistic value than did the standard EQ-5D index score in all known-group comparisons, with the F-statistic ratio ranging from 0.415 to 0.770.
CONCLUSIONS: The vision bolt-on EQ-5D appears to be more discriminative than the standard EQ-5D in measurement of vision problems. Future studies should investigate the extent to which the vision bolt-on item can increase the sensitivity of the EQ-5D to vision change in interventional studies.
Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EQ-5D; bolt-on; discriminatory power; vision problems; visual impairment

Mesh:

Year:  2015        PMID: 26686788     DOI: 10.1016/j.jval.2015.08.002

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  9 in total

1.  Exploration of a cultural-adaptation of the EQ-5D for Thai population: A "bolt-on" experiment.

Authors:  Krittaphas Kangwanrattanakul; Cynthia R Gross; Montaya Sunantiwat; Montarat Thavorncharoensap
Journal:  Qual Life Res       Date:  2018-12-05       Impact factor: 4.147

2.  Validation and comparison of five preference-based measures among age-related macular degeneration patients: evidence from mainland China.

Authors:  Yanhui Si; Shunping Li; Yanjiao Xu; Gang Chen
Journal:  Qual Life Res       Date:  2021-12-02       Impact factor: 4.147

3.  Standard Gamble to Derive Utility Health States for Limbal Stem Cell Deficiency.

Authors:  Adam B Smith; Jenny Retzler; Matthew J Taylor
Journal:  Clinicoecon Outcomes Res       Date:  2020-09-15

4.  EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.

Authors:  Mihir Gandhi; Marcus Ang; Kelvin Teo; Chee Wai Wong; Yvonne Chung-Hsi Wei; Rachel Lee-Yin Tan; Mathieu F Janssen; Nan Luo
Journal:  Patient       Date:  2019-08       Impact factor: 3.883

5.  Valuing health-related quality of life: systematic variation in health perception.

Authors:  Manuel Huber; Martin Vogelmann; Reiner Leidl
Journal:  Health Qual Life Outcomes       Date:  2018-08-02       Impact factor: 3.186

6.  EQ-5D-5L population norms and health inequalities for Trinidad and Tobago.

Authors:  Henry Bailey; Mathieu F Janssen; Althea La Foucade; Paul Kind
Journal:  PLoS One       Date:  2019-04-29       Impact factor: 3.240

7.  Exploring the Impact of Adding a Respiratory Dimension to the EQ-5D-5L.

Authors:  Martine Hoogendoorn; Mark Oppe; Melinde R S Boland; Lucas M A Goossens; Elly A Stolk; Maureen P M H Rutten-van Mölken
Journal:  Med Decis Making       Date:  2019-05-16       Impact factor: 2.583

8.  Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.

Authors:  Diane Whalley; Gary Globe; Rebecca Crawford; Lynda Doward; Eskinder Tafesse; John Brazier; David Price
Journal:  Health Qual Life Outcomes       Date:  2018-08-03       Impact factor: 3.186

9.  Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged "no-problems".

Authors:  Hideki Murasawa; Takayuki Sugiyama; Yuki Matsuoka; Takashi Okabe; Yoshiaki Wakumoto; Nobumichi Tanaka; Mikio Sugimoto; Masafumi Oyama; Kiyohide Fujimoto; Shigeo Horie; Masaru Funagoshi; Ichiro Arakawa; Shinichi Noto; Kojiro Shimozuma
Journal:  Qual Life Res       Date:  2019-10-03       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.